Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2351)
  2. Meeting Abstract (1873)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (101)
  6. Guidelines (40)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (23)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4752)
  2. Department of Medicine (4750)
  3. Center for Pancreatic Cancer Research (2317)
  4. Surgery (1067)
  5. Survivorship Research (1014)
  6. Epidemiology and Biostatistics (844)

More Groups

People
  1. Eileen O'Reilly (805)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (227)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (148)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (322)
  5. American Association for Cancer Research (282)
  6. Wiley Blackwell (243)

More Publishers

Results (4752)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic analysis of colitis-associated cancers
    Meeting Abstract

    Yaeger, R. D.; Miller, V. A.; Kelsen, J. R.; Wang, K.; He, Y. T.; Sanford, E. M.; Balasubramanian, S.; Tang, L. H.; Kelsen, D. P.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Prospective identification of potentially actionable molecular alterations in cancers of unknown primary
    Meeting Abstract

    Varghese, A. M.; Hyman, D. M.; Zehir, A.; Vakiani, E.; Klimstra, D. S.; Ladanyi, M.; Berger, M. F.; Solit, D. B.; Saltz, L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • nab-paclitaxel (nab-P) plus gemcitabine (Gem) vs Gem alone as adjuvant treatment for resected pancreatic cancer (PC) in a phase III trial (APACT)
    Meeting Abstract

    Tempero, M. A.; Cardin, D. B.; Biankin, A.; Goldstein, D.; Moore, M.; O'Reilly, E. M.; Philip, P. A.; Riess, H.; Macarulla, T.; Yung, L.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Recent and remote 30-day readmissions among cancer patients: Prevalence and association with overall survival
    Meeting Abstract

    Shahrokni, A.; Temple, L. K. F.; Mahmoudzadeh, S.; Wills, J.; Sepkowitz, K.; Martin, S.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Integration of multi-modality treatment planning for early stage breast cancer (BC) into Watson for Oncology, a Decision Support System: Seeing the forest and the trees
    Meeting Abstract

    Seidman, A. D.; Pilewskie, M. L.; Robson, M. E.; Kelvin, J. F.; Zauderer, M. G.; Epstein, A. S.; Kris, M. G.; Fu, J.; Keesing, J.; Caroline, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Safety and efficacy of MEDI4736, an anti-PD-L1 antibody, in patients from a squamous cell carcinoma of the head and neck (SCCHN) expansion cohort
    Meeting Abstract

    Segal, N. H.; Ou, S. H. I.; Balmanoukian, A. S.; Fury, M. G.; Massarelli, E.; Brahmer, J. R.; Weiss, J.; Schöffski, P.; Antonia, S. J.; Massard, C.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Safety and clinical activity of MEDI4736, an anti-programmed cell death-ligand 1 (PD-L1) antibody, in patients with non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Rizvi, N. A.; Brahmer, J. R.; Ou, S. H. I.; Segal, N. H.; Khleif, S.; Hwu, W. J.; Gutierrez, M.; Schöffski, P.; Hamid, O.; Weiss, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Treatment response and outcomes of grade 3 (G3) pancreatic neuroendocrine carcinomas (HGNEC) based on pathologic differentiation
    Meeting Abstract

    Raj, N. P.; Valentino, E.; Tang, L. H.; Capanu, M.; Basturk, O.; Klimstra, D.; Reidy, D. L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Prospective molecular analysis of small cell lung cancer (SCLC) using next generation sequencing (NGS)
    Meeting Abstract

    Pietanza, M. C.; Won, H. H.; Rekhtman, N.; Wang, L.; Travis, W. D.; Krug, L. M.; Varghese, A. M.; Paik, P. K.; Riely, G. J.; Zakowski, M. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • JANUS 2: A phase III study of survival, tumor response, and symptom response with ruxolitinib plus capecitabine or placebo plus capecitabine in patients with advanced or metastatic pancreatic cancer (mPC) who failed or were intolerant to first-line chemotherapy
    Meeting Abstract

    O'Reilly, E. M.; Walker, C.; Clark, J.; Brill, K. J.; Dawkins, F. W.; Bendell, J. C.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save